Navigation Links
Amarin in Medical News

RNA engineering to combat series of illnesses wins Kaye Award for Hebrew University dean

...profile and dosing regimen, as compared with the currently used drug, which targets the protein. In December 2007, Ester Neurosciences was acquired by amarin Corporation plc, a Nasdaq listed UK company. ...

Anthony Clarke, PhD Joins Alexza Pharmaceuticals as Vice President, International Development Operations

...program operations in international territories for Alexza's product candidates. Dr. Clarke was most recently Vice President, Clinical Development for amarin Corporation, based in the United Kingdom. Prior to Amarin, Dr. Clarke held positions as Director, Clinical Development and Independent Consultant fo...

Amarin Announces Private Placement for up to $60 Million

... DUBLIN, May 14 /PRNewswire-FirstCall/ -- amarin Corporation plc (NASDAQ: AMRN ) today announced a...ly over the next 12 months. Certain directors of amarin have indicated an interest in investing up to an a...eve reflects the attractive investment proposition amarin represents." The Company intends to use the proc...

Amarin Regains Compliance With Nasdaq Listing Requirements

... LONDON, February 11 /PRNewswire-FirstCall/ -- amarin Corporation plc (NASDAQ: AMRND ) today announced ...trengthened our management team." About Amarin amarin is committed to improving the lives of patients su...son's disease; one in epilepsy; and one in memory. amarin is initiating a series of cardiovascular preclinic...

Amarin Commences First Clinical Trial in Cardiovascular ProgramAmarin Commences First Clinical Trial in Cardiovascular Program

...ng LONDON, November 29 /PRNewswire-FirstCall/ -- amarin Corporation plc (NASDAQ: AMRN ) today announced t... our progress with these exciting new programs." amarin intends to develop its dyslipidemia and metabolic ...unsaturated fatty acids in cardiovascular disease. amarin plans to utilize its extensive know-how, intellect...

Amarin Announces Completion of Comprehensive Data Analysis From Phase III Huntington's Disease Program

... LONDON, November 19 /PRNewswire-FirstCall/ -- amarin Corporation plc (NASDAQ: AMRN ) ("Amarin" or "Com...zed to treatment with Miraxion at baseline. About amarin amarin is committed to improving the lives of patients su...

Pharmacopeia Announces Senior Additions to Management Team

...Senior Vice President, Strategic Planning at Questcor Pharmaceuticals and held executive-level positions with Enzon Pharmaceuticals, Elan Corporation, amarin Pharmaceuticals, and Athena Neurosciences. Mr. Liebler currently serves as Vice Chairman of the Board of Trustees of the American Academy of Neurology...
Amarin in Medical Technology

Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia

...DUBLIN, Ireland, July 22 /PRNewswire-FirstCall/ -- amarin Corporation plc (NASDAQ: AMRN ) today announced t... ethyl ester of eicosapentaenoic acid (Ethyl-EPA). amarin has collected a substantial body of data on AMR101 to date. amarin has previously investigated AMR101 in central nerv...

Amarin Reports Top-Line Results of two Phase III Studies of Miraxion in Huntington's Disease

...n both the U.S. and in Europe. Conference Call amarin management will host a conference call to discuss ...natural history and interventional trials. About amarin amarin is committed to improving the lives of patients su...
Amarin in Biological Technology

Amarin Announces Completion of the First Tranche of $60 Million Private Placement

...o Board DUBLIN, May 22 /PRNewswire-FirstCall/ -- amarin Corporation plc (NASDAQ: AMRN ) today announced t... $27 million. In conjunction with the financing, amarin has appointed to its Board representatives of the ...Capital. Non-executive directors retiring from the amarin Board are Mr. John Groom, Dr. Simon Kukes, Dr. Pre...

Amarin Announces Financial Results for Fourth Quarter and Full Year 2007

... DUBLIN, Ireland, May 19 /PRNewswire-FirstCall/ -- amarin Corporation plc (NASDAQ: AMRN ) ("Amarin" or "Com...December 31, 2007. For the fourth quarter of 2007, amarin reported a net loss of $7.9 million, or $0.72 per ...ion costs. For the year ended December 31, 2007, amarin reported a net loss of $38.2 million or $3.90 per ...

Amarin Secures Global Intellectual Property Rights for Lipid Programs

... LONDON, March 3 /PRNewswire-FirstCall/ -- amarin Corporation plc (NASDAQ: AMRN ) today announced t...n and royalties upon commercialization. In 2004, amarin licensed rights to this portfolio, covering applic...erica, the EU and Japan. This new license provides amarin with rights to all remaining therapeutic areas and...

Amarin Appoints Dr. William Mason as Lead Independent Director

... LONDON, February 4 /PRNewswire-FirstCall/ -- amarin Corporation plc (NASDAQ: AMRND ) today announced ...o that position follows the recent announcement by amarin that Thomas Lynch, Amarin's Chairman, has assumed ...ason has served as a non-executive board member of amarin since July 2002, is Chairman of the Company's Audi...

Amarin Provides Business Update and Announces Implementation of Reverse Stock Split

... LONDON, January 18 /PRNewswire-FirstCall/ -- amarin Corporation plc (NASDAQ: AMRND ) today announced ...iness yesterday, January 17, 2008. Thomas Lynch, amarin Chairman and Chief Executive Officer, commented "W...rom the U.S. Food and Drug Administration (FDA). amarin also conducted a thorough analysis and re-configur...

Amarin to Commence Phase II Trial With AMR101 in Age Associated Memory Impairment

... LONDON, January 10 /PRNewswire-FirstCall/ -- amarin Corporation plc (NASDAQ: AMRN ) today announced t...n all developed nations with aging populations." amarin had previously announced positive results from a p...ls who do not meet AAMI criteria. About Amarin amarin is committed to improving the lives of patients su...

Amarin Signs Agreement to Acquire Ester Neurosciences

...008 LONDON, December 5 /PRNewswire-FirstCall/ -- amarin Corporation plc (NASDAQ: AMRN ) today announced t... strategic fit for Amarin. This acquisition allows amarin to gain access to a unique mRNA platform technolog...on Preparations for the integration of Ester and amarin have already begun....

Amarin Corporation to Present at Acumen BioFin Rodman & Renshaw Ninth Annual Healthcare Conference

... LONDON, October 31 /PRNewswire-FirstCall/ -- amarin Corporation plc (NASDAQ: AMRN ) ("Amarin" or the ...ultaneously webcast and a link will be provided on amarin Corporation's website http://www.amarincorp.com . About amarin ...

Amarin Announces Initiation of Cardiovascular Development Strategy

...ase LONDON, October 10 /PRNewswire-FirstCall/ -- amarin Corporation plc (NASDAQ: AMRN ) today announced t...unsaturated fatty acids in cardiovascular disease. amarin plans to utilize its extensive know-how and experi... added value from our lipid technology platform." amarin intends to commence a series of clinical trials wi...

Amarin to Present at 4th Annual Bio Investor Forum

... LONDON, October 9 /PRNewswire-FirstCall/ -- amarin Corporation plc (NASDAQ: AMRN ) today announced t...ultaneously webcast and a link will be provided on amarin Corporation's website http://www.amarincorp.com . About amarin ...
Other Tags
(Date:4/24/2014)... me out to the ballgame, doesn,t exactly conjure up ... likely culprits include French fries, soda and the occasional ... play youth baseball, eating unhealthy food during practices and ... researchers at Wake Forest Baptist Medical Center. The study, ... Obesity , found that high-calorie snacks and sugar-sweetened drinks ...
(Date:4/24/2014)... the relevance of palliation in advanced cancer are ... trials (RCTs). This is the result of an ... Efficiency in Health Care (IQWiG), which has now ... external experts, IQWiG analysed studies on four solid ... and pancreatic cancer. For this purpose, the research ...
(Date:4/24/2014)... one of 30 grants from the National Cancer Institute ... in its new National Clinical Trials Network ... investigators charged with distributing resources in a more effective ... reflects recommendations from a 2010 Institute of Medicine ... Faster design, launch, and completion of clinical ...
(Date:4/23/2014)... pilot study by Massachusetts General Hospital (MGH) investigators may ... treatment for a serious medical problem use of ... caused by the Clostridium difficile ( C. ... online in the journal Clinical Infectious Diseases , ... material from donors unrelated to patients was as successful ...
(Date:4/23/2014)... M.D., scientific director at the National Institute of Arthritis ... the 2014 recipient of the Ross Prize in Molecular ... Molecular Medicine . The award will be given ... Sciences in Manhattan, followed by scientific presentations by Dr. ... the National Institutes of Health. , The award, which ...
Breaking Medicine News(10 mins):Health News:Take the bat, leave the candy 2Health News:Palliation is rarely a topic in studies on advanced cancer 2Health News:Palliation is rarely a topic in studies on advanced cancer 3Health News:Dartmouth awarded lead role in NCI clinical trials network 2Health News:Dartmouth awarded lead role in NCI clinical trials network 3Health News:Use of frozen material for fecal transplant successfully treats C. difficile infection 2Health News:Use of frozen material for fecal transplant successfully treats C. difficile infection 3Health News:NIH scientist to receive Ross Prize in Molecular Medicine 2
(Date:4/23/2014)... Huntington,s disease, most in their mid-thirties and forties, ... behavioral decline within two decades. "Mutant" protein clusters, ... disease, have been the primary focus of therapies ... new research from Prof. Gerardo Lederkremer and Dr. ... Cell Research and Immunology, in collaboration with Prof. ...
(Date:4/23/2014)... Valley, NY. (Apr. 23 2014) A ... neural stem cells (hNSCs) into the brains of ... after 22 and 24 months found that the ... and did not cause tumors. , The study ... Cell Transplantation but is currently freely ...
(Date:4/23/2014)... trope that the likelihood of an accurate group decision ... hold up when a collective faces a variety of ... Instead, Princeton University researchers report that smaller groups actually ... may become excessively focused on only certain pieces of ... what is known about collective intelligence, or the "wisdom ...
Breaking Biology News(10 mins):On the defensive 2On the defensive 3Study finds long-term survival of human neural stem cells transplanted into primate brain 2Too many chefs: Smaller groups exhibit more accurate decision-making 2Too many chefs: Smaller groups exhibit more accurate decision-making 3
Other Contents